Follow
Douglas Hanahan
Douglas Hanahan
Ludwig Institute for Cancer Reserch, and EPFL
Verified email at epfl.ch - Homepage
Title
Cited by
Cited by
Year
Hallmarks of cancer: the next generation
D Hanahan, RA Weinberg
cell 144 (5), 646-674, 2011
786082011
The hallmarks of cancer
D Hanahan, RA Weinberg
cell 100 (1), 57-70, 2000
439602000
Studies on transformation of Escherichia coli with plasmids
D Hanahan
Journal of molecular biology 166 (4), 557-580, 1983
160601983
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
D Hanahan, J Folkman
cell 86 (3), 353-364, 1996
100311996
Hallmarks of cancer: new dimensions
D Hanahan
Cancer discovery 12 (1), 31-46, 2022
59862022
Accessories to the crime: functions of cells recruited to the tumor microenvironment
D Hanahan, LM Coussens
Cancer cell 21 (3), 309-322, 2012
50502012
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
49012015
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers, R Brekken, G McMahon, TH Vu, T Itoh, K Tamaki, K Tanzawa, ...
Nature cell biology 2 (10), 737-744, 2000
34952000
Modes of resistance to anti-angiogenic therapy
G Bergers, D Hanahan
Nature Reviews Cancer 8 (8), 592-603, 2008
34622008
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
M Pàez-Ribes, E Allen, J Hudock, T Takeda, H Okuyama, F Viñals, ...
Cancer cell 15 (3), 220-231, 2009
28172009
Induction of angiogenesis during the transition from hyperplasia to neoplasia
J Folkman, K Watson, D Ingber, D Hanahan
Nature 339 (6219), 58-61, 1989
27701989
Techniques for transformation of E. coli.
D Hanahan
DNA cloning, 109-135, 1985
22781985
MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
TH Vu, JM Shipley, G Bergers, JE Berger, JA Helms, D Hanahan, ...
Cell 93 (3), 411-422, 1998
21451998
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas, DJ Hicklin, G Bergers, D Hanahan
Cancer cell 8 (4), 299-309, 2005
18832005
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
EA Collisson, A Sadanandam, P Olson, WJ Gibb, M Truitt, S Gu, J Cooc, ...
Nature medicine 17 (4), 500-503, 2011
18622011
Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
D Hanahan
Nature 315 (6015), 115-122, 1985
17921985
Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner
N Erez, M Truitt, P Olson, D Hanahan
Cancer cell 17 (2), 135-147, 2010
17362010
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
G Bergers, S Song, N Meyer-Morse, E Bergsland, D Hanahan
The Journal of clinical investigation 111 (9), 1287-1295, 2003
17032003
Signaling vascular morphogenesis and maintenance
D Hanahan
Science 277 (5322), 48-50, 1997
16791997
MMP-9 supplied by bone marrow–derived cells contributes to skin carcinogenesis
LM Coussens, CL Tinkle, D Hanahan, Z Werb
Cell 103 (3), 481-490, 2000
16502000
The system can't perform the operation now. Try again later.
Articles 1–20